Department of Anesthesiology
Author Title Type [ Year(Asc)]
Filters: Keyword is Nerve Tissue Proteins  [Clear All Filters]
2015
Calder EL, Tchieu J, Steinbeck JA, Tu E, Keros S, Ying S-W, Jaiswal MK, Cornacchia D, Goldstein PA, Tabar V et al..  2015.  Retinoic Acid-Mediated Regulation of GLI3 Enables Efficient Motoneuron Derivation from Human ESCs in the Absence of Extrinsic SHH Activation.. J Neurosci. 35(33):11462-81.
2014
Rangaraju V, Calloway N, Ryan TA.  2014.  Activity-driven local ATP synthesis is required for synaptic function.. Cell. 156(4):825-35.
2009
Herold KF, Nau C, Ouyang W, Hemmings HC.  2009.  Isoflurane inhibits the tetrodotoxin-resistant voltage-gated sodium channel Nav1.8.. Anesthesiology. 111(3):591-9.
2008
Balaji J, Armbruster M, Ryan TA.  2008.  Calcium control of endocytic capacity at a CNS synapse.. J Neurosci. 28(26):6742-9.
2007
S Bullock A, Platholi J, Gjyrezi A, Heerdt PM, Tung HYLim, Hemmings HC.  2007.  Differential regulation of protein phosphatase-1(I) by neurabin.. Biochem Biophys Res Commun. 358(1):140-4.
Mani M, Lee SYoon, Lucast L, Cremona O, Di Paolo G, De Camilli P, Ryan TA.  2007.  The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals.. Neuron. 56(6):1004-18.
Snyder GL, Galdi S, Hendrick JP, Hemmings HC.  2007.  General anesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo.. Neuropharmacology. 53(5):619-30.
2006
Fernandez-Alfonso T, Kwan R, Ryan TA.  2006.  Synaptic vesicles interchange their membrane proteins with a large surface reservoir during recycling.. Neuron. 51(2):179-86.
2005
Cacheaux LP, Topf N, Tibbs GR, Schaefer UR, Levi R, Harrison NL, Abbott GW, Goldstein PA.  2005.  Impairment of hyperpolarization-activated, cyclic nucleotide-gated channel function by the intravenous general anesthetic propofol.. J Pharmacol Exp Ther. 315(2):517-25.
Mitchell SJ, Ryan TA.  2005.  Munc18-dependent regulation of synaptic vesicle exocytosis by syntaxin-1A in hippocampal neurons.. Neuropharmacology. 48(3):372-80.
Futter M, Uematsu K, Bullock SA, Kim Y, Hemmings HC, Nishi A, Greengard P, Nairn AC.  2005.  Phosphorylation of spinophilin by ERK and cyclin-dependent PK 5 (Cdk5).. Proc Natl Acad Sci U S A. 102(9):3489-94.
Fu D, Vissavajjhala P, Hemmings HC.  2005.  Volatile anaesthetic effects on phospholipid binding to synaptotagmin 1, a presynaptic Ca2+ sensor.. Br J Anaesth. 95(2):216-21.
2004
Bálint E, Kitka T, Zachar G, Adám A, Hemmings HC, Csillag A.  2004.  Abundance and location of DARPP-32 in striato-tegmental circuits of domestic chicks.. J Chem Neuroanat. 28(1-2):27-36.
Nicholson-Tomishima K, Ryan TA.  2004.  Kinetic efficiency of endocytosis at mammalian CNS synapses requires synaptotagmin I.. Proc Natl Acad Sci U S A. 101(47):16648-52.
Mitchell SJ, Ryan TA.  2004.  Syntaxin-1A is excluded from recycling synaptic vesicles at nerve terminals.. J Neurosci. 24(20):4884-8.
2002
Albert KA, Hemmings HC, Adamo AIB, Potkin SG, Akbarian S, Sandman CA, Cotman CW, Bunney WE, Greengard P.  2002.  Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia.. Arch Gen Psychiatry. 59(8):705-12.
Shahani SK, Lingamaneni R, Hemmings HC.  2002.  General anesthetic actions on norepinephrine, dopamine, and gamma-aminobutyric acid transporters in stably transfected cells.. Anesth Analg. 95(4):893-9,tableofcontents.
2001
Absil P, Foidart A, Hemmings HC, Steinbusch HW, Ball GF, Balthazart J.  2001.  Distribution of DARPP-32 immunoreactive structures in the quail brain: anatomical relationship with dopamine and aromatase.. J Chem Neuroanat. 21(1):23-39.
2000
Caporaso GL, Bibb JA, Snyder GL, Valle C, Rakhilin S, Fienberg AA, Hemmings HC, Nairn AC, Greengard P.  2000.  Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia.. Neuropharmacology. 39(9):1637-44.
Sankaranarayanan S, Ryan TA.  2000.  Real-time measurements of vesicle-SNARE recycling in synapses of the central nervous system.. Nat Cell Biol. 2(4):197-204.
1999
Mayerhofer A, Hemmings HC, Snyder GL, Greengard P, Boddien S, Berg U, Brucker C.  1999.  Functional dopamine-1 receptors and DARPP-32 are expressed in human ovary and granulosa luteal cells in vitro.. J Clin Endocrinol Metab. 84(1):257-64.
Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ et al..  1999.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.. Nature. 402(6762):669-71.
McAvoy T, Allen PB, Obaishi H, Nakanishi H, Takai Y, Greengard P, Nairn AC, Hemmings HC.  1999.  Regulation of neurabin I interaction with protein phosphatase 1 by phosphorylation.. Biochemistry. 38(39):12943-9.
1998
Durstewitz D, Kröner S, Hemmings HC, Güntürkün O.  1998.  The dopaminergic innervation of the pigeon telencephalon: distribution of DARPP-32 and co-occurrence with glutamate decarboxylase and tyrosine hydroxylase.. Neuroscience. 83(3):763-79.
1997
Schnabel R, Metzger M, Jiang S, Hemmings HC, Greengard P, Braun K.  1997.  Localization of dopamine D1 receptors and dopaminoceptive neurons in the chick forebrain.. J Comp Neurol. 388(1):146-68.